Approps Committees To Shift As Fiscal 2021 Funding Hangs In Balance

By Kelly Lienhard / November 5, 2020 at 12:57 PM
House appropriators might get the chance to rethink funding priorities for FDA, especially as the House Appropriations Committee, which will still be led by Democrats, faces leadership changes and appropriators face the possibility of having to reconsider a previously House-passed fiscal 2021 funding bill. There’s still uncertainty about which party controls the Senate, as of Thursday afternoon (Nov. 5), but sources say if Democrats take the lead, they could seek more funding for domestic programs at FDA. If Congress doesn’t...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.